These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23995163)

  • 1. Sibutramine-associated psychotic symptoms and zolpidem-induced complex behaviours: implications for patient safety.
    Wiglusz MS; Cubała WJ; Nowak P; Jakuszkowiak-Wojten K; Landowski J; Krysta K
    Psychiatr Danub; 2013 Sep; 25 Suppl 2():S143-5. PubMed ID: 23995163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
    Lee J; Teoh T; Lee TS
    J Psychosom Res; 2008 Jan; 64(1):107-9. PubMed ID: 18158006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibutramine-associated psychotic episode.
    Taflinski T; Chojnacka J
    Am J Psychiatry; 2000 Dec; 157(12):2057-8. PubMed ID: 11097984
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychosis with sibutramine.
    Rosenbohm A; Bux CJ; Connemann BJ
    J Clin Psychopharmacol; 2007 Jun; 27(3):315-7. PubMed ID: 17502790
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adverse drug reactions of a slimming product contaminated with sibutramine].
    van Hunsel F; van Grootheest K
    Ned Tijdschr Geneeskd; 2011; 155(42):A3695. PubMed ID: 22027464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sibutramine-associated psychosis (case report).
    Gazdag G; Szabó Z
    Neuropsychopharmacol Hung; 2008 May; 10(2):107-10. PubMed ID: 18959143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolpidem-induced psychosis.
    Markowitz JS; Brewerton TD
    Ann Clin Psychiatry; 1996 Jun; 8(2):89-91. PubMed ID: 8807033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk-benefit profile of sibutramine.
    Scheen AJ
    Am J Cardiovasc Drugs; 2010; 10(5):321-34. PubMed ID: 20860415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sibutramine and psychosis.
    Litvan L; Alcoverro-Fortuny O
    J Clin Psychopharmacol; 2007 Dec; 27(6):726-7. PubMed ID: 18004153
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of psychosis associated with Pai You Guo slimming capsules containing sibutramine.
    Shah KA; Abraham MA; Espinosa JB
    J Clin Psychiatry; 2015 Jul; 76(7):e893-4. PubMed ID: 26231019
    [No Abstract]   [Full Text] [Related]  

  • 11. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sibutramine associated psychotic episode: a case report].
    Figueroa C RA; Castaño C C
    Rev Med Chil; 2008 May; 136(5):671-3. PubMed ID: 18769818
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychotic reactions to zolpidem.
    Ansseau M; Pitchot W; Hansenne M; Gonzalez Moreno A
    Lancet; 1992 Mar; 339(8796):809. PubMed ID: 1347827
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.
    Maggioni AP; Caterson I; Coutinho W; Finer N; Gaal LV; Sharma AM; Torp-Pedersen C; Bacher P; Shepherd G; Sun R; James P;
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):393-402. PubMed ID: 19033818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ; Wilton LV; Shakir SA
    Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misuse of sibutramine and bulimia nervosa: a dangerous combination.
    Ferreira GM; Nazar BP; da Silva MR; Carriello MA; Freitas S; Appolinario JC
    Braz J Psychiatry; 2018; 40(3):343. PubMed ID: 30043896
    [No Abstract]   [Full Text] [Related]  

  • 17. Sibutramine-associated QT interval prolongation and cardiac arrest.
    Ernest D; Gershenzon A; Corallo CE; Nagappan R
    Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe symptomatic hyponatremia during sibutramine therapy: a case report.
    Esposito P; Rampino T; Gregorini M; Soccio G; Piotti G; Bedino G; Balenzano CT; Roscini E; Cosmai L; Portalupi V; Libetta C; Dal Canton A
    Am J Kidney Dis; 2008 Jul; 52(1):137-9. PubMed ID: 18487000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient global amnesia after taking sibutramine: a case report.
    Fu PK; Hsu HY; Wang PY
    Neurologist; 2010 Mar; 16(2):129-31. PubMed ID: 20220452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.